Filing Flows › Insmed (INSM) › Guidance & outlook
Insmed (INSM) guidance and outlook
Insmed (INSM) raised its guidance on Oct 29, 2026: Revenue $1.4B for FY2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $1.4B | raised |
| Revenue | FY2026 | $1.4B | raised |
From the earnings release filed Oct 29, 2026 (8-K on EDGAR).
Insmed's latest quarter
Insmed, Q3 2026: revenue $524M (+268% year over year), operating margin -17.0%, net loss $100M, operating cash flow −$36.5M. The chart follows the revenue to costs, profit and cash.
Questions
Did Insmed raise or lower its guidance?
Insmed (INSM) raised its guidance on Oct 29, 2026: Revenue $1.4B for FY2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.